An elderly couple who hired a contractor to renovate their roof claims they were scammed out of tens of thousands of dollars, ...

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...

A 77-year-old Vermont man was killed on Sunday afternoon while attempting to rescue a turtle on Interstate 95 in Indian River ...

Friends and neighbors are remembering the elderly woman who lost her life in this weekend’s fire in Maili as a kind soul who ...

Many in the MAGA movement are in a state of anger and disbelief over the Justice Department and FBI’s memo disclosing that ...

There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...

The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...

My sister has caused major issues at the assisted living facility, which greatly upsets my poor mother, since she loves the ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.

What started as a conversation between two retired teachers has turned into a growing mission of service — one screen door, ...